Mylanta Coat & Cool Interactions
There are 432 drugs known to interact with Mylanta Coat & Cool (calcium carbonate / magnesium hydroxide / simethicone), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 12 are major, 362 are moderate, and 58 are minor.
- View all 432 medications that may interact with Mylanta Coat & Cool
- View Mylanta Coat & Cool alcohol/food interactions (1)
- View Mylanta Coat & Cool disease interactions (8)
Most frequently checked interactions
View interaction reports for Mylanta Coat & Cool (calcium carbonate / magnesium hydroxide / simethicone) and the medicines listed below.
- acetaminophen
- alprazolam
- atorvastatin
- azelastine nasal
- baclofen
- Benadryl (diphenhydramine)
- biotin
- buspirone
- calcium citrate
- chromium picolinate
- clindamycin
- diclofenac topical
- estradiol
- ezetimibe
- Flonase (fluticasone nasal)
- gabapentin
- hydroxyzine
- ibuprofen
- levothyroxine
- lisinopril
- magnesium citrate
- magnesium oxide
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- pantoprazole
- Pepto-Bismol (bismuth subsalicylate)
- sertraline
- simethicone
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Mylanta Coat & Cool alcohol/food interactions
There is 1 alcohol/food interaction with Mylanta Coat & Cool (calcium carbonate / magnesium hydroxide / simethicone).
Mylanta Coat & Cool disease interactions
There are 8 disease interactions with Mylanta Coat & Cool (calcium carbonate / magnesium hydroxide / simethicone) which include:
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
More about Mylanta Coat & Cool (calcium carbonate / magnesium hydroxide / simethicone)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.